SEC Comment Letter 0000000000-23-007239 to DarioHealth Corp. (DRIO)
DarioHealth Corp.
Date: July 7, 2023 · CIK: 0001533998 · Accession: 0000000000-23-007239
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273019
Letter
United States securities and exchange commission logo July 6, 2023 Erez Raphael Chief Executive Officer DarioHealth Corp. 18 W. 18th St. New York, New York Re:DarioHealth Corp. Registration Statement on Form S-3 Filed June 29, 2023 File No. 333-273019 Dear Erez Raphael: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Ron Ben-Bassat, Esq.
Show Raw Text
United States securities and exchange commission logo
July 6, 2023
Erez Raphael
Chief Executive Officer
DarioHealth Corp.
18 W. 18th St.
New York, New York
Re:DarioHealth Corp.
Registration Statement on Form S-3
Filed June 29, 2023
File No. 333-273019
Dear Erez Raphael:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Schwartz at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Ron Ben-Bassat, Esq.